Finally, findings demonstrating different phosphorylation patterns of LASP1 in breast cancer and chronic myeloid leukemia may have implications for CXCR4 function and tyrosine kinase inhibitor treatment. This evidence concerns the gene CXCR4 and chronic myelogenous leukemia, BCR-ABL1 positive.